Pole Exonuclease Mutant Colon Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-10-07
Clinical Trial Update: Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer [Phase 3]
Phase 3 trial evaluating avelumab plus 5-FU–based chemotherapy as adjuvant treatment for stage III colon cancer with POLE exonuclease mutati…